Taken together, our work strongly supports that C/EBP-β/AEP signaling plays a critical role in atherosclerosis pathogenesis, and blockade of AEP with its specific inhibitor may provide a powerful therapeutic agent for treating this cardiovascular disorder. The gene discussed is CEBPB; the disease is cardiovascular disorder.